SCHEMBL28628118

SCHEMBL28628118

CCOC(=O)c1cc2n(n1)CC(C)C2

nearest known ligand 0.44

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 2/20 0.43
▸ CYP1A2 P05177 1/20 0.40
▸ GAA P10253 2/20 0.38
▸ ADORA3 P0DMS8 1/20 0.37
▸ FAAH O00519 2/20 0.36
▸ KDM4E B2RXH2 1/20 0.36
▸ POLB P06746 1/20 0.36
▸ LMNA P02545 1/20 0.36
▸ MAPK1 P28482 1/20 0.36
▸ ATM Q13315 1/20 0.36
▸ MAPT P10636 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31389863 0.88 ATM (0.43) KMT2ACYP1A2GAAFAAHPOLB
SCHEMBL31389606 0.86 KMT2A (0.44) KMT2ACYP1A2GAAFAAHKDM4E
SCHEMBL28923147 0.85 KMT2A (0.42) KMT2ACYP1A2GAAADORA3FAAH
SCHEMBL28923148 0.85 KMT2A (0.42) KMT2ACYP1A2GAAADORA3FAAH
SCHEMBL30682082 0.84 KMT2A (0.39) KMT2ACYP1A2GAAADORA3FAAH
SCHEMBL27152236 0.80 KMT2A (0.46) KMT2ACYP1A2GAAADORA3FAAH
SCHEMBL27146168 0.76 KMT2A (0.38) KMT2ACYP1A2GAAFAAHLMNA
SCHEMBL2927030 0.74 CYP1A2 (0.41) KMT2ACYP1A2GAAADORA3KDM4E
SCHEMBL2929174 0.74 NPC1 (0.41) KMT2ACYP1A2GAAKDM4ELMNA
SCHEMBL28633824 0.73 KMT2A (0.52) KMT2ACYP1A2GAAADORA3FAAH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113429410-B Polyheterocyclic substituted pyrimidine or pyridylamine derivatives, compositions and medical uses thereof 上海海雁医药科技有限公司 2022-10-04 — — CN disclosed
CN-113429410-A Polyheterocyclic substituted pyrimidine or pyridylamine derivatives, compositions and medical uses thereof 上海海雁医药科技有限公司 2021-09-24 — — CN disclosed
Send feedback